BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 21454309)

  • 21. Increased incidence of Sjogren's syndrome in systemic sclerosis: A nationwide population study.
    Tseng CC; Yen JH; Tsai WC; Ou TT; Wu CC; Sung WY; Hsieh MC; Chang SJ
    Autoimmunity; 2015; 48(7):438-44. PubMed ID: 25980318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Isolated sensory neuropathy of the trigeminal and Sjögren's syndrome: scleroderma?].
    Froissart M; Mizon JP; Morcamp D
    Rev Otoneuroophtalmol; 1980; 52(5):453-8. PubMed ID: 7209255
    [No Abstract]   [Full Text] [Related]  

  • 23. [Sjögren's syndrome in systemic scleroderma].
    Guseva NG; Simonova MV; Kirtava ZZ; Shcherbakov AB
    Ter Arkh; 1988; 60(4):54-6. PubMed ID: 3394099
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Systemic scleroderma : salivary immunoglobulins and the Gougerot-Sjögren syndrome].
    Fiessinger JN; Jarnet J; Capron L; Housset E
    Biomed Pharmacother; 1982 Jan; 36(1):51-4. PubMed ID: 7126773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ro(SSA) and La(SSB) antibodies in the clinical spectrum of Sjögren's syndrome.
    Alexander EL; Hirsch TJ; Arnett FC; Provost TT; Stevens MB
    J Rheumatol; 1982; 9(2):239-46. PubMed ID: 7097683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical aspects, diagnosis and combined treatment of Sjögren's syndrome].
    Solntsev AM; Kolesov VS; Sakharchuk VM
    Vrach Delo; 1981 Jul; (7):93-6. PubMed ID: 7281627
    [No Abstract]   [Full Text] [Related]  

  • 27. Pyoderma gangrenosum in Sjögren's syndrome and its successful treatment with topical application of etanercept.
    Haridas V; Shetty P; Dsouza LC; Dinesh US; Haridas K; Bargale A
    Int J Rheum Dis; 2017 May; 20(5):657-659. PubMed ID: 28419761
    [No Abstract]   [Full Text] [Related]  

  • 28. Relationship of Sjögren's syndrome to other connective tissue and autoimmune disorders.
    Theander E; Jacobsson LT
    Rheum Dis Clin North Am; 2008 Nov; 34(4):935-47, viii-ix. PubMed ID: 18984413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of additional autoimmune diseases in a population of patients with primary Sjögren's syndrome.
    Lazarus MN; Isenberg DA
    Ann Rheum Dis; 2005 Jul; 64(7):1062-4. PubMed ID: 15958760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sjögren's syndrome in progressive systemic sclerosis.
    Drosos AA; Andonopoulos AP; Costopoulos JS; Stavropoulos ED; Papadimitriou CS; Moutsopoulos HM
    J Rheumatol; 1988 Jun; 15(6):965-8. PubMed ID: 3418646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence of thromboembolic events in patients with primary Sjögren's syndrome.
    Haga HJ; Jacobsen EM; Peen E
    Scand J Rheumatol; 2008; 37(2):127-9. PubMed ID: 18415770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary Sjögren's syndrome complicated by anti-neutrophil cytoplasmic antibody-mediated crescentic glomerulonephritis.
    Ghorbel IB; Belfeki N; Salem TB; Houman MH
    Saudi J Kidney Dis Transpl; 2017; 28(5):1184-1187. PubMed ID: 28937084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Immunosuppression in Sjogren's syndrome with a pseudo-leukemic lymphocyte reaction].
    Orlowski Z; Jedrzejewska T
    Pol Tyg Lek; 1970 Oct; 25(42):1588-9. PubMed ID: 5476524
    [No Abstract]   [Full Text] [Related]  

  • 34. [Characteristics of keratoconjunctivitis sicca in Sjögren's disease and syndrome].
    Safonova TN; Iudina IuV
    Ter Arkh; 1988; 60(4):30-1. PubMed ID: 3394092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The presence of Sjögren's syndrome is a major determinant of the pattern of interstitial lung disease in scleroderma and other connective tissue diseases.
    Breit SN; Cairns D; Szentirmay A; Callaghan T; Murray D; Wacher T; Gibson PG; Marks G; Bryant DH; Yeates M
    J Rheumatol; 1989 Aug; 16(8):1043-9. PubMed ID: 2585401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Annular erythema associated with Sjögren's syndrome preceding overlap syndrome of rheumatoid arthritis and polymyositis with anti-PL-12 autoantibodies.
    Sugiura K; Muro Y; Akiyama M
    Acta Derm Venereol; 2014 Jul; 94(4):470-1. PubMed ID: 24322624
    [No Abstract]   [Full Text] [Related]  

  • 37. [Anticentromere antibodies in rheumatoid polyarthritis with Sjögren syndrome, without the elements of the CREST syndrome].
    Lorcerie B; Tavernier C; Olsson O; Strauss J; Martin F
    Rev Rhum Mal Osteoartic; 1988 Mar; 55(4):291-2. PubMed ID: 3259719
    [No Abstract]   [Full Text] [Related]  

  • 38. What is Sjögren's syndrome and why is it important?
    Talal N
    J Rheumatol Suppl; 2000 Dec; 61():1-3. PubMed ID: 11128697
    [No Abstract]   [Full Text] [Related]  

  • 39. Management of patients presenting with Sjogren's syndrome.
    Venables PJ
    Best Pract Res Clin Rheumatol; 2006 Aug; 20(4):791-807. PubMed ID: 16979538
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathologic quiz case 2. Primary Sjögren's syndrome (SS).
    Dolan R; Gnepp DR
    Arch Otolaryngol Head Neck Surg; 1988 Oct; 114(10):1190-3. PubMed ID: 3415836
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.